219 related articles for article (PubMed ID: 28635233)
1. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma].
Wang JF; Zhu XH; Tan Z; Ge MH
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):434-438. PubMed ID: 28635233
[No Abstract] [Full Text] [Related]
2. Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G
Thyroid; 2014 Nov; 24(11):1600-6. PubMed ID: 25110922
[TBL] [Abstract][Full Text] [Related]
3. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
4. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
[TBL] [Abstract][Full Text] [Related]
5. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery.
Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N
Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in anaplastic thyroid carcinoma: An Australian experience.
So K; Smith RE; Davis SR
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):279-287. PubMed ID: 28387011
[TBL] [Abstract][Full Text] [Related]
10. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.
Lennon P; Deady S; Healy ML; Toner M; Kinsella J; Timon CI; O'Neill JP
Head Neck; 2016 Apr; 38 Suppl 1():E1122-9. PubMed ID: 26879282
[TBL] [Abstract][Full Text] [Related]
12. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
[TBL] [Abstract][Full Text] [Related]
13. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
[TBL] [Abstract][Full Text] [Related]
16. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
[TBL] [Abstract][Full Text] [Related]
17. Survival and prognostic factors of anaplastic thyroid carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for Korean patients with anaplastic thyroid carcinoma.
Kim TY; Kim KW; Jung TS; Kim JM; Kim SW; Chung KW; Kim EY; Gong G; Oh YL; Cho SY; Yi KH; Kim WB; Park DJ; Chung JH; Cho BY; Shong YK
Head Neck; 2007 Aug; 29(8):765-72. PubMed ID: 17274052
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
Käsmann L; Bolm L; Janssen S; Rades D
Anticancer Res; 2016 Sep; 36(9):4697-700. PubMed ID: 27630315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]